The surprising outperformance of a new drug against existing competitors, and other biotech updates
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we see a
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we see a
Merck’s Keytruda notched another positive set of data, this time in a rare cancer of the esophagus that sets up the company to receive full
Dietary and lifestyle habits among individuals living with chronic pain.